The Department of Health has decided to remove Etoposide Preparation under Government-Mediated Access Price (GMAP). To learn more about the changes, you can access the full contents here.
Advisory for the Request for Inputs and Recommendations on the Proposed Amendments to the Joint Administrative Order on the Implementing Guidelines of the Price Negotiation Board
Click the title to read more about the advisory.
Removal of Methotrexate and Mitomycin Preparations in the Government Mediated Access Price (GMAP) List
The Department of Health has decided to remove several medicines under Government-Mediated Access Price (GMAP). To learn more about the changes, you can access the full contents here.
Government-Mediated Access Price (GMAP) Adjustment of Salmeterol + Fluticasone Propionate
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav, Dutasteride and Paroxetine
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
Pharmaceutical Division Citizens Charter for the Electronic Drug Price Monitoring System
The Citizens Charter for the Electronic Drug Price Monitoring System contains several steps and processes focused on certification and registration. To learn more about the Charter, please click on the link.
Removal of Metronidazole and Glibenclamide Preparations in the Government-Mediated Access Price (GMAP) List
The Department of Health has removed certain medicines from the Government-Mediated Access Price (GMAP) list. For more details on these changes, you can access the full information of the circular here.
Advisory for the Public Consultation on the Draft Administrative Order entitled “Revised Implementing Guidelines on the Electronic Drug Price Monitoring System”
Republic Act No. 9502, otherwise known as the “Universally Accessible Cheaper and Quality Medicines Act of 2008,” mandated the Secretary of Health (SOH)to establish and initiate an electronic price monitoring and regulation system for drugs and medicines which is now known as the Electronic Drug Price Monitoring System (EDPMS).
Click the title to read more about the advisory.
Advisory on the adjustments in the price of the medicines under GMAP
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
DOH updates list of VAT-Exempt Medicines under RA 11354
The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.